University of Toledo Health Science Campus

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, University of Toledo Health Science Campus sits in the top decile of US sponsors by registered trial count (#604 of 15,742 sponsors by registered trial count).

26 total trials none currently recruiting 19 completed top decile by trial count

University of Toledo Health Science Campus: 26 sponsored US clinical trials, none currently recruiting.

University of Toledo Health Science Campus sponsors 26 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 19 completed. 3 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Ulnar Neuropathy, with 1 trials.

Top-decile sponsor footprint

University of Toledo Health Science Campus ranks in the top decile of sponsors by registered trial count (#604 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 37/100

19 of 24 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (79.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

26 total, page 1 of 1

ACTIVE NOT RECRUITING

Models for Improving Operating Room Productivity: Delays, Cancellations and Pre-admission Testing

NCT02525406

ACTIVE NOT RECRUITING

Validation of a Multi-gene Test for Lung Cancer Risk

NCT01130285

COMPLETED Early Phase 1

Platelet Rich Plasma in Knee Osteoarthritis

NCT05080075

COMPLETED Phase 4

Fluoxetine to Reduce Intubation and Death After COVID19 Infection

NCT04377308

TERMINATED NA

Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena.

NCT03869008

COMPLETED NA

Social Determinants of Health Screening and Interventions

NCT03661359

TERMINATED NA

Evaluation of the Percutaneous SCS Trial Using the DSSEP Collision Testing

NCT02614079

COMPLETED NA

Preoperative Prevalence of Ulnar Neuropathy and Changes in Ulnar Nerve Latency During Surgery

NCT02533024

COMPLETED Phase 4

Fade Upon TOF Stimulation Induced by Succinylcholine

NCT02425449

COMPLETED NA

Clinical Trial To Study The Anti-scarring Effect Of Cicatricell

NCT03020420

TERMINATED

Noninvasive Blood Glucose Monitoring Method Based on Imaging of the Eye

NCT02236364

TERMINATED NA

Effectiveness of Sorbion in the Treatment of Venous Leg Ulcers The Protocol Elements

NCT03020446

COMPLETED NA

Electromyography in Patients on Chronic Pyridostigmine Therapy

NCT02364180

COMPLETED Phase 4

Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Everolimus/Reduced Tacrolimus in Renal Transplant Recipients Following Campath® Induction

NCT01935128

COMPLETED Early Phase 1

Pneumonia Vaccine in Aging HIV Positive Individuals

NCT02558751

COMPLETED

Clinical Comparison of Electrocardiograms Collected Using an Ambulatory Holter

NCT02383667

COMPLETED

Predicting Ankle Injury Through Clinical Functional Measures in Adolescent Athletes

NCT01658709

COMPLETED NA

Cranial Electrotherapy Stimulation in the Treatment of Migraine Headaches

NCT01265797

COMPLETED

The Regulation of Pulmonary Vascular Resistance in Patients With Heart Failure

NCT02275793

COMPLETED NA

The Effect of Five-Toed Socks on Postural Control Among Active Individuals Who Have Chronic Ankle Instabilities

NCT01210612

COMPLETED Early Phase 1

Immune Response to Pneumococcal Vaccination in HIV Infected Individuals

NCT02515240

TERMINATED NA

Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney Disease

NCT00638222

COMPLETED NA

Assessment Of Infrared Photobiotherapy for Improved Wound Healing

NCT00426166

COMPLETED NA

Effects of Therapeutic Touch on Osteoarthritis of the Knee

NCT00759512

COMPLETED NA

Hemodynamic Effects of Spironolactone in Patients With Heart Failure

NCT00860340

COMPLETED Phase 2

Prospective Randomized Study Comparing Renal Artery Stenting (RESIST)With/Without Distal Protection

NCT00234585

Phase Distribution

PhaseTrial count
Phase 1 3
Phase 2 1
Phase 4 3

How the University of Toledo Health Science Campus archive is shaped

26 indexed studies, none listed as recruiting (0% open); 19 completed (73%).

Phase mix: 3 late (III/IV) vs 4 early (I/II) (balanced across stages).

Top condition: Ulnar Neuropathy (1 trial), 4 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

University of Toledo Health Science Campus: archived-pipeline peers nationwide

Peers matched on 26 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

University of Toledo Health Science Campus sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0102030 0%5%10%15%20%25% Total trials Recruiting share University of Toledo Health Science CampusAbbott Diabetes CareAldeyra TherapeuticsCalifornia Polytechnic State University-San Luis ObispoDexCom10xBio22nd Century Group23andMe3-C Institute for Social Development
University of Toledo Health Science Campus sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Toledo Health Science Campus sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 26 archived trials

Sponsors with similar archive density (± trial count)

What to do with this University of Toledo Health Science Campus page

26 registered trials is a research-attention snapshot, not an endorsement of University of Toledo Health Science Campus or any single study.

  • None of University of Toledo Health Science Campus's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Ulnar Neuropathy is the condition University of Toledo Health Science Campus studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Ulnar Neuropathy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of Toledo Health Science Campus pipeline card: 26 registered trials from official public datasets.Report a data error.